Combination of a renin inhibitor and an insulin secretion enhancer or an insulin sensitizer

Details for Australian Patent Application No. 2006265653 (hide)

Owner Novartis AG

Inventors Ali, Mohammed Atif; Prescott, Margaret Forney

Agent Davies Collison Cave

Pub. Number AU-A-2006265653

PCT Pub. Number WO2007/005763

Priority 60/696,252 01.07.05 US

Filing date 28 June 2006

Wipo publication date 11 January 2007

International Classifications

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 31/165 (2006.01) - having aromatic rings, e.g. colchicine, atenolol, progabide

A61K 31/445 (2006.01) - Non-condensed piperidines, e.g. piperocaine

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

Event Publications

28 February 2008 PCT application entered the National Phase

  PCT publication WO2007/005763 Priority application(s): WO2007/005763

30 September 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006265665-Ink warping for normalization and beautification / ink beautification

2006265652-Two piece draft gear housing having an integral yoke